Long-term results of endovascular intervention with unibody bifurcation endograft for elective abdominal aortic aneurysm management

Basit Öğe Kaydı
dc.authoridUnal, Ertekin Utku / 0000-0002-1144-8906
dc.authorwosidUnal, Ertekin Utku / G-2728-2013
dc.contributor.authorIscan, Hakki Zafer
dc.contributor.authorKarahan, Mehmet
dc.contributor.authorAkkaya, Bekir Bogachan
dc.contributor.authorBasar, Veysel
dc.contributor.authorAskin, Goktan
dc.contributor.authorKubat, Emre
dc.contributor.authorUnal, Ertekin Utku
dc.date.accessioned2021-11-01T15:06:06Z
dc.date.available2021-11-01T15:06:06Z
dc.date.issued2021
dc.department[Belirlenecek]
dc.description.abstractUnibody bifurcated endografts have the advantage of reducing the operative time, avoiding migration and iliac limb dislocation in patient with abdominal aortic aneurysm (AAA). We report our longterm experience in patients who underwent endovascular aortic repair (EVAR) due to infrarenal AAA with Endologix AFX (R) endograft system. Between January 2013-December 2018, 68 patients with infrarenal AAA had EVAR procedure with Endologix AFX (R) endograft system. Mean follow-up was 40.4 +/- 19.5 months, and all patients had computed tomography periodically, with colored Doppler ultra-sonography (CDUS) every six months. Mean age was 68.5 +/- 7.1 years and, 63 (92.6%) patients were male. Early mortality, renal complications, stent-graft migration and cardiac complications were not seen in early post-operative period. There was no early mortality in the group and no conversion to open repair. In long-term follow-up 12 patients (17.6%) had endoleak (5 with type II, 7 with type III). Overall survival estimated by Kaplan-Meier analysis was 94.1% at 1 year, 85.2% at 2 years, 74.1% at 3 years and 54.0% at 5 years. Freedom from second intervention and conversion was 98.4% at 1 year, 95.3% at 2 years, 93.3% at 3 years and 87.4% at 5 years. Endologix AFX (R) endo-graft provides a fast, safe and effective endograft for the early period, therefore it seems more suitable for elderly and comorbid patients. This endograft has low reintervention rates however according to our results, aneurysms larger than 6 cm may have more sideway displacement possibility and by this way type III endoleak. Proper patient selection and sufficient overlap are the key issues. Close monitoring is mandatory at the follow-up period.
dc.identifier.doi10.31083/j.rcm2202051
dc.identifier.endpage459en_US
dc.identifier.issn1530-6550
dc.identifier.issn2153-8174
dc.identifier.issue2en_US
dc.identifier.pmid34258912
dc.identifier.scopus2-s2.0-85111065516
dc.identifier.scopusqualityQ3
dc.identifier.startpage453en_US
dc.identifier.urihttps://doi.org/10.31083/j.rcm2202051
dc.identifier.urihttps://hdl.handle.net/11491/7492
dc.identifier.volume22en_US
dc.identifier.wosWOS:000672805600023
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.institutionauthor[Belirlenecek]
dc.language.isoen
dc.publisherImr Press
dc.relation.ispartofReviews In Cardiovascular Medicine
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectAbdominal aortic aneurysmen_US
dc.subjectEndovascular proceduresen_US
dc.subjectCumulative survival rateen_US
dc.subjectEndoleaksen_US
dc.titleLong-term results of endovascular intervention with unibody bifurcation endograft for elective abdominal aortic aneurysm management
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu